Taken together, these findings confirm ALK-rearrangement as a strong risk factor for VTE in NSCLC and suggest the need for studies investigating thromboprophylaxis strategies in patients with ALK-positive NSCLC. Here, ALK is linked to non-small cell lung carcinoma.